RE: Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor

Tony's Diary Package, pp.899-900 · fauci_diary:email:00038

Date: 2021-10-11 12:46
Type: email · email
sender: Peter Staley
to: Kessler, David Kessler, Anthony S. Fauci, James Krellenstein, Jeffrey Zients
Topics: Vaccines Intelligence community assessments

This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.

James should know what COVAX is saying. From our view, if you don't count the badly underperforming vaccines, then we'll need about 4 billion doses more than currently promised. And buying doses still matters, especially since we waited this long to look at manufacturing. I know you got burned with Emergent, but J&J should be back in the mix at this point. Cheers, Peter ] <afauci@niaid.nih.gov>; I of Poor D.Zients@who.eop.gov I of Poor } I of Poor

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2021-10-11 07:55 Peter Staley open

Adding Jeff. If you all had used the DPA to setup a GoCo factory with Lonza back in February, we'd be delivering millions of doses of NIAID's vaccine to low income countries right now. Instead, you still won't talk directly to Lonza (even though their CEO has told us he's ready to talk to you) because you fear offending Moderna. Jeff, David, Tony--let me be frank. You all need to grow a pair. James will be sending an email soon suggesting we hash all of this out over good food and wine in DC soon. I hope you're all up for it. Peter Sent from my iPhone
2021-10-11 12:33 David Kessler open

Peter How many mrna doses to you want delivered to l/lmic countries by end of 2022 beyond what we and covax/au have already contracted for? What do you understand Covax to be saying the gap is? d
2021-10-11 12:46 Peter Staley

James should know what COVAX is saying. From our view, if you don't count the badly underperforming vaccines, then we'll need about 4 billion doses more than currently promised. And buying doses still matters, especially since we waited this long to look at manufacturing. I know you got burned with Emergent, but J&J should be back in the mix at this point. Cheers, Peter ] <afauci@niaid.nih.gov>; I of Poor D.Zients@who.eop.gov I of Poor } I of Poor
2021-10-11 13:04 David Kessler open

Jeremey How should I respond to Peter. Seems like the discrepancy between what Covax and the activists are saying is a key issue. ThAnks D Sent from my iPhone

Full conversation →